ITeos Therapeutics Inc (ITOS)
10.60
+0.03
(+0.28%)
USD |
NASDAQ |
Apr 25, 16:00
10.60
0.00 (0.00%)
After-Hours: 20:00
ITeos Therapeutics Total Assets (Quarterly): 667.59M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 667.59M |
| September 30, 2023 | 677.64M |
| June 30, 2023 | 703.75M |
| March 31, 2023 | 728.35M |
| December 31, 2022 | 754.99M |
| September 30, 2022 | 777.87M |
| June 30, 2022 | 814.77M |
| March 31, 2022 | 850.32M |
| December 31, 2021 | 884.71M |
| Date | Value |
|---|---|
| September 30, 2021 | 922.38M |
| June 30, 2021 | 318.68M |
| March 31, 2021 | 332.89M |
| December 31, 2020 | 344.56M |
| September 30, 2020 | 350.94M |
| June 30, 2020 | 145.21M |
| March 31, 2020 | 153.97M |
| December 31, 2019 | 30.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
30.74M
Minimum
Dec 2019
922.38M
Maximum
Sep 2021
556.43M
Average
677.64M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 62.12B |
| Merck & Co Inc | 106.68B |
| Arcus Biosciences Inc | 1.095B |
| IGM Biosciences Inc | 423.41M |
| Forian Inc | 58.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 92.36M |
| Shareholders Equity (Quarterly) | 575.23M |